pipette
ESEspañol

Small quantity lipid-based nutritional supplementation and measles vaccination coverage in children aged 6−23 months: a pragmatic cluster-randomized trial

Cécile Cazes, Baba Waru Goni, Delphine Gabillard, Olumuyiwa Adeyemi Owolabi, Brice Yapi, Juliet Nabunje, Irine Atanga, Ariong’o M. Akinyi, Serge Danho, Éric Balestre, Anani Badje, Fatima Idriss, Mohammed Kasim, Muhammad M. Audu Bukarti, Chikezie Ugonna Emeka, Michelle Chouinard, Jean-Paul Mushenvula, Soma Bahonan, Mélanie Plazy, Ousmane Abdoulaye, Umar Chiroma, Hadiza Maina Adam, Camille Montfort, Nuru Suleiman Muhammad, Renaud Becquet, Kevin P. Q. Phelan

Peer-reviewed journalReal-world use

In the authors' words

Undernutrition and infectious diseases pose a double threat to child survival, especially in areas with a high malnutrition burden and low vaccination coverage. In this study, we evaluated whether distributing preventive small-quantity lipid-based nutrient supplements (SQ-LNS) alongside routine immunization services may increase vaccine uptake in a pediatric, pragmatic, cluster-randomized controlled trial in northern Nigeria. Twenty geographically defined clusters across two Local Government Areas were randomized 1:1 to the NutriVax strategy (intervention) or standard National Program of Immunization (NPI) services (control). NutriVax provided a monthly ration of SQ-LNS to children aged 6−23 months after routine NPI delivery at primary healthcare centers. The primary outcome was coverage of the first dose of measles-containing vaccine (MCV1) verified by vaccination card among children aged 12−23 months, assessed in an endline population-based household cross-sectional survey 12 months after conducting a similar baseline survey. The endline survey included 1,604 children (801 control, 803 NutriVax); 48% of children surveyed in intervention clusters had ever received SQ-LNS. The odds of receiving card-verified MCV1 were two times higher in the NutriVax arm than in the control arm (odds ratio = 2.08, 95% confidence interval (CI): 1.30−3.35, P = 0.004). The difference-in-differences, cluster conditional analysis indicated a 20.1 percentage-point (pp) increase in MCV1 coverage from baseline (95% CI: 13.7−26.5 pp, P < 0.0001) relative to the control arm. Co-delivering SQ-LNS with routine immunization substantially improved card-verified MCV1 uptake, supporting a scalable strategy to make progress toward targets set by the World Health Organizationʼs Immunization Agenda 2030 in similar settings. ClinicalTrials.gov identifier: NCT06387511 . A pragmatic, superiority, cluster-randomized trial done in Yobe State, northern Nigeria, found that distributing small-quantity lipid-based nutrient supplements alongside routine immunization services substantially increased measles vaccination uptake in children aged 12−23 months.

Main resultThe abstract does not state a limitation.

Appeared: Sunday, October 4. Nature Medicine. Peer-reviewed journal.

DOI: 10.1038/s41591-026-04675-1